Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lipid-lowering therapy after coronary revascularization.

J J Popma1, M Sawyer, A P Selwyn

  • 1Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.

The American Journal of Cardiology
|October 6, 2000
PubMed
Summary

Aggressively manage atherosclerosis with risk factor modification and lipid-lowering therapy to prevent cardiac events after coronary revascularization. Early and late management strategies are crucial for improving patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Psychophysical Relationships Between Perceived Sweetness and Color in Cherry-Flavored Beverages.

Journal of food protection·2019
Same author

Quick Hot Shot & Young Surgeon Presentation.

Hernia : the journal of hernias and abdominal wall surgery·2015
Same author

The male nurse in China proves valuable.

The Trained nurse and hospital review·2010
Same author

Impact of clinical practice guidelines on the management for carcinomas of unknown primary site: a controlled "before-after" study.

Bulletin du cancer·2009
Same author

Development and evaluation of a standardized questionnaire for identifying adverse events in vaccine clinical trials.

Pharmacoepidemiology and drug safety·2008
Same author

Impact of clinical practice guidelines on the diagnostic strategy for carcinomas of unknown primary site: a controlled 'before-after' study.

Clinical oncology (Royal College of Radiologists (Great Britain))·2008

Area of Science:

  • Cardiology
  • Vascular Medicine
  • Preventive Cardiology

Background:

  • Atherosclerosis often remains asymptomatic and undertreated, despite significant clinical implications.
  • Lumen irregularities identified during angiography necessitate aggressive management strategies.
  • Current treatment paradigms include risk factor modification, medical therapy, and coronary revascularization.

Purpose of the Study:

  • To review the management of symptomatic coronary artery disease.
  • To emphasize the dual goals of relieving stenosis and preventing future events.
  • To highlight the role of lipid-lowering therapy and risk factor modification.

Main Methods:

  • Review of randomized clinical trials demonstrating benefits of lipid reduction therapy.

Related Experiment Videos

  • Analysis of indications for coronary revascularization in acute coronary syndromes.
  • Evaluation of factors contributing to late cardiac events post-percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG).

    • Main Results:

    • Lipid reduction therapy shows both angiographic and clinical benefits.
    • Coronary revascularization is indicated for symptom relief in high-risk patients.
    • Late events post-PCI relate to restenosis or new atherosclerotic disease; post-CABG events often involve graft degeneration.
    • Diabetes mellitus increases risk for late coronary events.

    Conclusions:

    • Effective management requires addressing flow-limiting stenosis and preventing future events through aggressive lipid lowering and risk factor modification.
    • Lipid-lowering therapy after revascularization prevents plaque instability and graft disease.
    • Shared accountability among patients, specialists, and primary care physicians is essential for risk-factor modification.